Rank | Gene Set | Z-score |
---|---|---|
1 | cell adhesion mediated by integrin (GO:0033627) | 4.64047122 |
2 | synaptic vesicle maturation (GO:0016188) | 4.43100190 |
3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.32611643 |
4 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.13309446 |
5 | neuronal action potential propagation (GO:0019227) | 4.10412236 |
6 | Golgi transport vesicle coating (GO:0048200) | 4.09342852 |
7 | COPI coating of Golgi vesicle (GO:0048205) | 4.09342852 |
8 | synaptic vesicle exocytosis (GO:0016079) | 4.06385693 |
9 | glutamate secretion (GO:0014047) | 4.00887708 |
10 | locomotory exploration behavior (GO:0035641) | 3.93004150 |
11 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.92137112 |
12 | skin morphogenesis (GO:0043589) | 3.80989085 |
13 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.67726645 |
14 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.53623495 |
15 | vocalization behavior (GO:0071625) | 3.52571340 |
16 | cellular potassium ion homeostasis (GO:0030007) | 3.49906882 |
17 | * protein localization to endosome (GO:0036010) | 3.47061244 |
18 | neuron cell-cell adhesion (GO:0007158) | 3.46456852 |
19 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.40313030 |
20 | regulation of synaptic vesicle transport (GO:1902803) | 3.38835724 |
21 | protein retention in ER lumen (GO:0006621) | 3.37649493 |
22 | endodermal cell differentiation (GO:0035987) | 3.36872775 |
23 | neurotransmitter secretion (GO:0007269) | 3.36289971 |
24 | gamma-aminobutyric acid transport (GO:0015812) | 3.34752646 |
25 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.34220135 |
26 | hemidesmosome assembly (GO:0031581) | 3.27702721 |
27 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.26288218 |
28 | layer formation in cerebral cortex (GO:0021819) | 3.20226847 |
29 | apoptotic cell clearance (GO:0043277) | 3.20148472 |
30 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.19761805 |
31 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.17613750 |
32 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.17314538 |
33 | hypotonic response (GO:0006971) | 3.12758515 |
34 | barbed-end actin filament capping (GO:0051016) | 3.11938901 |
35 | exploration behavior (GO:0035640) | 3.10115823 |
36 | protein localization to synapse (GO:0035418) | 3.07511511 |
37 | neuron recognition (GO:0008038) | 3.06563633 |
38 | mating behavior (GO:0007617) | 3.04924157 |
39 | stress fiber assembly (GO:0043149) | 3.01696083 |
40 | glutamate receptor signaling pathway (GO:0007215) | 2.98415908 |
41 | dendritic spine morphogenesis (GO:0060997) | 2.97640161 |
42 | surfactant homeostasis (GO:0043129) | 2.97292973 |
43 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.96679962 |
44 | cell-substrate junction assembly (GO:0007044) | 2.94856218 |
45 | activation of protein kinase A activity (GO:0034199) | 2.93393167 |
46 | transmission of nerve impulse (GO:0019226) | 2.92072266 |
47 | cortical actin cytoskeleton organization (GO:0030866) | 2.91058994 |
48 | central nervous system myelination (GO:0022010) | 2.90981876 |
49 | axon ensheathment in central nervous system (GO:0032291) | 2.90981876 |
50 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.90570585 |
51 | sodium ion export (GO:0071436) | 2.90337949 |
52 | regulation of early endosome to late endosome transport (GO:2000641) | 2.89727679 |
53 | neurotransmitter transport (GO:0006836) | 2.89436771 |
54 | substrate-dependent cell migration (GO:0006929) | 2.88969079 |
55 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.87959247 |
56 | neuron-neuron synaptic transmission (GO:0007270) | 2.86910501 |
57 | positive regulation of receptor recycling (GO:0001921) | 2.85209238 |
58 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.84564422 |
59 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.84351157 |
60 | synaptic transmission, glutamatergic (GO:0035249) | 2.82400295 |
61 | wound healing, spreading of epidermal cells (GO:0035313) | 2.82241887 |
62 | negative regulation of neurotransmitter transport (GO:0051589) | 2.79052617 |
63 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.78619548 |
64 | vesicle coating (GO:0006901) | 2.77796756 |
65 | axonal fasciculation (GO:0007413) | 2.76936748 |
66 | proline transport (GO:0015824) | 2.76669332 |
67 | dendrite morphogenesis (GO:0048813) | 2.75064869 |
68 | regulation of synapse structural plasticity (GO:0051823) | 2.72928238 |
69 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.69864575 |
70 | neuromuscular process controlling posture (GO:0050884) | 2.69795476 |
71 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.68504192 |
72 | potassium ion import (GO:0010107) | 2.68395540 |
73 | vesicle transport along microtubule (GO:0047496) | 2.68063444 |
74 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.68046290 |
75 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.66520508 |
76 | regulation of neurotransmitter levels (GO:0001505) | 2.66033259 |
77 | presynaptic membrane assembly (GO:0097105) | 2.65435940 |
78 | regulation of vesicle fusion (GO:0031338) | 2.63778982 |
79 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.63427631 |
80 | basement membrane organization (GO:0071711) | 2.61302229 |
81 | long-term memory (GO:0007616) | 2.60018234 |
82 | cortical cytoskeleton organization (GO:0030865) | 2.59367451 |
83 | L-amino acid import (GO:0043092) | 2.58466340 |
84 | negative regulation of fatty acid transport (GO:2000192) | 2.58041498 |
85 | regulation of postsynaptic membrane potential (GO:0060078) | 2.57056574 |
86 | positive regulation of membrane potential (GO:0045838) | 2.56852369 |
87 | regulation of synaptic plasticity (GO:0048167) | 2.56839506 |
88 | glycine transport (GO:0015816) | 2.56598027 |
89 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.56210032 |
90 | long-term synaptic potentiation (GO:0060291) | 2.56118341 |
91 | presynaptic membrane organization (GO:0097090) | 2.55268230 |
92 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.55267342 |
93 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.54691942 |
94 | neuromuscular process controlling balance (GO:0050885) | 2.54576756 |
95 | positive regulation of osteoblast proliferation (GO:0033690) | 2.51095284 |
96 | regulation of beta-amyloid formation (GO:1902003) | 2.50916939 |
97 | negative regulation of anoikis (GO:2000811) | 2.50689872 |
98 | wound healing, spreading of cells (GO:0044319) | 2.50689776 |
99 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.49776069 |
100 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.49607872 |
101 | protein targeting to Golgi (GO:0000042) | 2.49480692 |
102 | regulation of neurotransmitter secretion (GO:0046928) | 2.49234252 |
103 | membrane raft organization (GO:0031579) | 2.48713329 |
104 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.48541812 |
105 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.48376968 |
106 | organelle transport along microtubule (GO:0072384) | 2.48091604 |
107 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.48043383 |
108 | collagen metabolic process (GO:0032963) | 2.47102858 |
109 | detection of calcium ion (GO:0005513) | 2.46409752 |
110 | suckling behavior (GO:0001967) | 2.46156925 |
111 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.44861525 |
112 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.44360591 |
113 | potassium ion homeostasis (GO:0055075) | 2.44112969 |
114 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.43632500 |
115 | collagen fibril organization (GO:0030199) | 2.43491943 |
116 | neuron remodeling (GO:0016322) | 2.42748957 |
117 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.42745781 |
118 | positive regulation of potassium ion transport (GO:0043268) | 2.42579673 |
119 | chondrocyte proliferation (GO:0035988) | 2.41957583 |
120 | nerve growth factor signaling pathway (GO:0038180) | 2.41179444 |
121 | neuronal ion channel clustering (GO:0045161) | 2.40518820 |
122 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.40416985 |
123 | adherens junction assembly (GO:0034333) | 2.40065643 |
124 | mesodermal cell differentiation (GO:0048333) | 2.39400790 |
125 | collagen catabolic process (GO:0030574) | 2.39226310 |
126 | regulation of ARF protein signal transduction (GO:0032012) | 2.38684487 |
127 | cellular copper ion homeostasis (GO:0006878) | 2.38396323 |
128 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.37517570 |
129 | membrane depolarization during action potential (GO:0086010) | 2.37271010 |
130 | regulation of dendritic spine development (GO:0060998) | 2.37005476 |
131 | COPII vesicle coating (GO:0048208) | 2.36691692 |
132 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.36655113 |
133 | cellular response to vitamin (GO:0071295) | 2.36596459 |
134 | response to methylmercury (GO:0051597) | 2.35999942 |
135 | adult walking behavior (GO:0007628) | 2.35714577 |
136 | regulation of extracellular matrix disassembly (GO:0010715) | 2.35455293 |
137 | synapse assembly (GO:0007416) | 2.34026876 |
138 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.33016103 |
139 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.32557605 |
140 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.32498848 |
141 | regulation of neurotransmitter transport (GO:0051588) | 2.32450038 |
142 | synapse organization (GO:0050808) | 2.32433366 |
143 | cell-substrate adherens junction assembly (GO:0007045) | 2.32380941 |
144 | focal adhesion assembly (GO:0048041) | 2.32380941 |
145 | response to auditory stimulus (GO:0010996) | 2.32270659 |
146 | membrane protein ectodomain proteolysis (GO:0006509) | 2.32150120 |
147 | cellular sodium ion homeostasis (GO:0006883) | 2.31837836 |
148 | membrane depolarization (GO:0051899) | 2.31698235 |
149 | cerebellar granule cell differentiation (GO:0021707) | 2.31228803 |
150 | extracellular matrix disassembly (GO:0022617) | 2.31179828 |
151 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.30196163 |
152 | establishment of protein localization to Golgi (GO:0072600) | 2.29292917 |
153 | positive regulation of fibroblast migration (GO:0010763) | 2.28351365 |
154 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.28291359 |
155 | semaphorin-plexin signaling pathway (GO:0071526) | 2.27384498 |
156 | innervation (GO:0060384) | 2.27380079 |
157 | behavioral response to cocaine (GO:0048148) | 2.26312035 |
158 | positive regulation of macrophage cytokine production (GO:0060907) | 2.25813105 |
159 | response to laminar fluid shear stress (GO:0034616) | 2.24374902 |
160 | clathrin coat assembly (GO:0048268) | 2.24194115 |
161 | positive regulation of axon extension (GO:0045773) | 2.23795519 |
162 | peptidyl-proline hydroxylation (GO:0019511) | 2.20922808 |
163 | multicellular organismal catabolic process (GO:0044243) | 2.19764989 |
164 | cellular response to vitamin D (GO:0071305) | 2.19497889 |
165 | protein hydroxylation (GO:0018126) | 2.19432630 |
166 | epithelial cell-cell adhesion (GO:0090136) | 2.19085911 |
167 | multicellular organismal metabolic process (GO:0044236) | 2.18087130 |
168 | embryonic process involved in female pregnancy (GO:0060136) | 2.17268448 |
169 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.16659519 |
170 | virion attachment to host cell (GO:0019062) | 2.16483782 |
171 | adhesion of symbiont to host cell (GO:0044650) | 2.16483782 |
172 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.16377975 |
173 | regulation of macrophage cytokine production (GO:0010935) | 2.16310853 |
174 | chondrocyte development (GO:0002063) | 2.16294570 |
175 | amino acid import (GO:0043090) | 2.15546292 |
176 | endocytic recycling (GO:0032456) | 2.13862756 |
177 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.12678551 |
178 | regulation of anoikis (GO:2000209) | 2.11858616 |
179 | localization within membrane (GO:0051668) | 2.10173986 |
180 | import into cell (GO:0098657) | 2.09136715 |
181 | extracellular matrix assembly (GO:0085029) | 2.08445554 |
182 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.07792945 |
183 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.05177135 |
184 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.04742862 |
185 | actin filament bundle assembly (GO:0051017) | 2.03708448 |
186 | actin filament bundle organization (GO:0061572) | 2.03708448 |
187 | chemical homeostasis within a tissue (GO:0048875) | 2.03679190 |
188 | protein targeting to plasma membrane (GO:0072661) | 2.02843164 |
189 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.02634771 |
190 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 2.01673282 |
191 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.01670609 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.18072961 |
2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.13617314 |
3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.63830272 |
4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.07522198 |
5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.76402490 |
6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.76401012 |
7 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.71122703 |
8 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.49248794 |
9 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.36882861 |
10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.34432105 |
11 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.34432105 |
12 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.33611633 |
13 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.32774906 |
14 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.31180233 |
15 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.30771841 |
16 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.20835195 |
17 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.20482970 |
18 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.18194606 |
19 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.11476545 |
20 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.09141053 |
21 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.03657187 |
22 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.01531754 |
23 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.01483219 |
24 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.99172666 |
25 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.99064432 |
26 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.96707870 |
27 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.96312675 |
28 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.93623105 |
29 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.92512889 |
30 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.92154390 |
31 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.89843332 |
32 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.89488692 |
33 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.89455459 |
34 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.88182565 |
35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.86994857 |
36 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.85857887 |
37 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.84734938 |
38 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.83113811 |
39 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.82582935 |
40 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.77177484 |
41 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.76466537 |
42 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.76399453 |
43 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.73507528 |
44 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.65508775 |
45 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.60792475 |
46 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.59248972 |
47 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.59076457 |
48 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.59076457 |
49 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.58623158 |
50 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.57115084 |
51 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.54181881 |
52 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.53283828 |
53 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.53247942 |
54 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.52514036 |
55 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.50607064 |
56 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.49989395 |
57 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.47623307 |
58 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.46482224 |
59 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.46376380 |
60 | KDM2B_26808549_Chip-Seq_K562_Human | 1.45821218 |
61 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.45417545 |
62 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.44931899 |
63 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.44449054 |
64 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.44375597 |
65 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.44258766 |
66 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.43778059 |
67 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.43576472 |
68 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.42430165 |
69 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.41538703 |
70 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.39224328 |
71 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.38560815 |
72 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.38257895 |
73 | CJUN_26792858_Chip-Seq_BT549_Human | 1.36766612 |
74 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.35721874 |
75 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.35222571 |
76 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.34285170 |
77 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.33863603 |
78 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.33243824 |
79 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.32573197 |
80 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.32573197 |
81 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.31057780 |
82 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.30371212 |
83 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.29572668 |
84 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.29560936 |
85 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.28729286 |
86 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.28596121 |
87 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.27452589 |
88 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.26671643 |
89 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.25429431 |
90 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.24852747 |
91 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.24524604 |
92 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.23403919 |
93 | STAT3_23295773_ChIP-Seq_U87_Human | 1.23334118 |
94 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.22426151 |
95 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.21507041 |
96 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.21377119 |
97 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.21085748 |
98 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.20781901 |
99 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.19643871 |
100 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.19499773 |
101 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.19383897 |
102 | AR_25329375_ChIP-Seq_VCAP_Human | 1.17745243 |
103 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.17195791 |
104 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.15967342 |
105 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.14968659 |
106 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.14433684 |
107 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.14408639 |
108 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.13993374 |
109 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.13798502 |
110 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.12975767 |
111 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.12683841 |
112 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.11925953 |
113 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.11910886 |
114 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.11409098 |
115 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.11409098 |
116 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.11013463 |
117 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.09849763 |
118 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.08980542 |
119 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.08527470 |
120 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.08370174 |
121 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.07944496 |
122 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.07444294 |
123 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.07390049 |
124 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.06306110 |
125 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.04165830 |
126 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.04006561 |
127 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.03801626 |
128 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.03749334 |
129 | VDR_22108803_ChIP-Seq_LS180_Human | 1.03574716 |
130 | AR_19668381_ChIP-Seq_PC3_Human | 1.01778831 |
131 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.01641452 |
132 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01047113 |
133 | TCF4_23295773_ChIP-Seq_U87_Human | 0.99780487 |
134 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.99720172 |
135 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99600841 |
136 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.99446649 |
137 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.99335713 |
138 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.98094078 |
139 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.97936137 |
140 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.97880036 |
141 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.97751909 |
142 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.97093711 |
143 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.96648803 |
144 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.96225565 |
145 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 0.96103401 |
146 | * TP53_16413492_ChIP-PET_HCT116_Human | 0.95768337 |
147 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.95581549 |
148 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.95396990 |
149 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.95352834 |
150 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.95340716 |
151 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.94114505 |
152 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.93862603 |
153 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93454258 |
154 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.93083153 |
155 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.91975767 |
156 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.91483223 |
157 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.90940460 |
158 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.90849092 |
159 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.90807045 |
160 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.90782387 |
161 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88924536 |
162 | RXR_22108803_ChIP-Seq_LS180_Human | 0.88684051 |
163 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.88675334 |
164 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.88222173 |
165 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.87748873 |
166 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.87365500 |
167 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.87052783 |
168 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.86429327 |
169 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.84400593 |
170 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.84086517 |
171 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.83497911 |
172 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.83333698 |
173 | * P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.83273451 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0008438_abnormal_cutaneous_collagen | 5.23951979 |
2 | MP0004859_abnormal_synaptic_plasticity | 5.03235302 |
3 | MP0003880_abnormal_central_pattern | 4.19774362 |
4 | MP0003705_abnormal_hypodermis_morpholog | 4.16764621 |
5 | MP0004270_analgesia | 3.58093929 |
6 | MP0003635_abnormal_synaptic_transmissio | 3.48455221 |
7 | MP0004272_abnormal_basement_membrane | 3.28141178 |
8 | MP0003566_abnormal_cell_adhesion | 3.22035004 |
9 | MP0002877_abnormal_melanocyte_morpholog | 3.14305415 |
10 | MP0001958_emphysema | 3.08806637 |
11 | MP0009745_abnormal_behavioral_response | 2.86818950 |
12 | MP0002064_seizures | 2.84564277 |
13 | MP0002063_abnormal_learning/memory/cond | 2.69648779 |
14 | MP0003329_amyloid_beta_deposits | 2.66320897 |
15 | MP0009046_muscle_twitch | 2.65910796 |
16 | MP0003091_abnormal_cell_migration | 2.65539711 |
17 | MP0003300_gastrointestinal_ulcer | 2.65038110 |
18 | MP0003279_aneurysm | 2.62086228 |
19 | MP0005275_abnormal_skin_tensile | 2.58161529 |
20 | MP0001968_abnormal_touch/_nociception | 2.55134671 |
21 | MP0002272_abnormal_nervous_system | 2.44739200 |
22 | MP0003191_abnormal_cellular_cholesterol | 2.40819619 |
23 | MP0009780_abnormal_chondrocyte_physiolo | 2.40408199 |
24 | MP0010352_gastrointestinal_tract_polyps | 2.35493386 |
25 | MP0005257_abnormal_intraocular_pressure | 2.35349173 |
26 | MP0002734_abnormal_mechanical_nocicepti | 2.33869231 |
27 | MP0002572_abnormal_emotion/affect_behav | 2.29937670 |
28 | MP0001486_abnormal_startle_reflex | 2.25852930 |
29 | MP0010368_abnormal_lymphatic_system | 2.13408656 |
30 | MP0005058_abnormal_lysosome_morphology | 2.12881571 |
31 | MP0002909_abnormal_adrenal_gland | 2.07137931 |
32 | MP0001440_abnormal_grooming_behavior | 2.04269265 |
33 | MP0001501_abnormal_sleep_pattern | 2.00196779 |
34 | MP0002735_abnormal_chemical_nociception | 1.99992808 |
35 | MP0002733_abnormal_thermal_nociception | 1.95845942 |
36 | MP0002822_catalepsy | 1.93203645 |
37 | MP0002736_abnormal_nociception_after | 1.91038368 |
38 | MP0005423_abnormal_somatic_nervous | 1.90916019 |
39 | MP0006054_spinal_hemorrhage | 1.89420774 |
40 | MP0000920_abnormal_myelination | 1.86558739 |
41 | MP0001970_abnormal_pain_threshold | 1.80571310 |
42 | MP0002067_abnormal_sensory_capabilities | 1.77649898 |
43 | MP0002896_abnormal_bone_mineralization | 1.73786490 |
44 | MP0000013_abnormal_adipose_tissue | 1.69762190 |
45 | MP0005409_darkened_coat_color | 1.65864030 |
46 | MP0003690_abnormal_glial_cell | 1.65777080 |
47 | MP0004885_abnormal_endolymph | 1.63607367 |
48 | MP0005023_abnormal_wound_healing | 1.60970349 |
49 | MP0000604_amyloidosis | 1.59801814 |
50 | MP0004858_abnormal_nervous_system | 1.59056222 |
51 | MP0008569_lethality_at_weaning | 1.56875515 |
52 | MP0005386_behavior/neurological_phenoty | 1.56786652 |
53 | MP0004924_abnormal_behavior | 1.56786652 |
54 | MP0003633_abnormal_nervous_system | 1.54946856 |
55 | MP0006276_abnormal_autonomic_nervous | 1.54936872 |
56 | MP0004043_abnormal_pH_regulation | 1.53246691 |
57 | MP0003941_abnormal_skin_development | 1.48598497 |
58 | MP0000767_abnormal_smooth_muscle | 1.47335739 |
59 | MP0003828_pulmonary_edema | 1.46804553 |
60 | MP0002060_abnormal_skin_morphology | 1.46669853 |
61 | MP0000778_abnormal_nervous_system | 1.44349007 |
62 | MP0001542_abnormal_bone_strength | 1.44199027 |
63 | MP0008260_abnormal_autophagy | 1.41495130 |
64 | MP0002184_abnormal_innervation | 1.40981725 |
65 | MP0000955_abnormal_spinal_cord | 1.40030799 |
66 | MP0009840_abnormal_foam_cell | 1.39934760 |
67 | MP0001348_abnormal_lacrimal_gland | 1.39924743 |
68 | MP0005503_abnormal_tendon_morphology | 1.36574417 |
69 | MP0003195_calcinosis | 1.36431739 |
70 | MP0002139_abnormal_hepatobiliary_system | 1.35813854 |
71 | MP0002557_abnormal_social/conspecific_i | 1.34097575 |
72 | MP0002066_abnormal_motor_capabilities/c | 1.30879533 |
73 | MP0001849_ear_inflammation | 1.30777266 |
74 | MP0004811_abnormal_neuron_physiology | 1.30525451 |
75 | MP0001915_intracranial_hemorrhage | 1.30449462 |
76 | MP0002837_dystrophic_cardiac_calcinosis | 1.28814170 |
77 | MP0002998_abnormal_bone_remodeling | 1.26947613 |
78 | MP0003631_nervous_system_phenotype | 1.25771777 |
79 | MP0003634_abnormal_glial_cell | 1.25767786 |
80 | MP0003448_altered_tumor_morphology | 1.23901673 |
81 | MP0005646_abnormal_pituitary_gland | 1.23473719 |
82 | MP0004142_abnormal_muscle_tone | 1.23306941 |
83 | MP0003303_peritoneal_inflammation | 1.22519870 |
84 | MP0002229_neurodegeneration | 1.20397593 |
85 | MP0005164_abnormal_response_to | 1.20033150 |
86 | MP0001905_abnormal_dopamine_level | 1.20007679 |
87 | MP0002882_abnormal_neuron_morphology | 1.19762813 |
88 | MP0002295_abnormal_pulmonary_circulatio | 1.19304483 |
89 | MP0004782_abnormal_surfactant_physiolog | 1.19123143 |
90 | MP0005535_abnormal_body_temperature | 1.18557409 |
91 | MP0005165_increased_susceptibility_to | 1.17101434 |
92 | MP0001984_abnormal_olfaction | 1.16716548 |
93 | MP0010386_abnormal_urinary_bladder | 1.16188935 |
94 | MP0000858_altered_metastatic_potential | 1.15968776 |
95 | MP0002133_abnormal_respiratory_system | 1.15727919 |
96 | MP0005388_respiratory_system_phenotype | 1.15727919 |
97 | MP0008004_abnormal_stomach_pH | 1.13854786 |
98 | MP0003453_abnormal_keratinocyte_physiol | 1.13767661 |
99 | MP0001529_abnormal_vocalization | 1.12131918 |
100 | MP0001502_abnormal_circadian_rhythm | 1.07992267 |
101 | MP0004742_abnormal_vestibular_system | 1.07803614 |
102 | MP0003879_abnormal_hair_cell | 1.07662733 |
103 | MP0004145_abnormal_muscle_electrophysio | 1.07167815 |
104 | MP0005645_abnormal_hypothalamus_physiol | 1.06255462 |
105 | MP0006082_CNS_inflammation | 1.02722721 |
106 | MP0001879_abnormal_lymphatic_vessel | 1.00614653 |
107 | MP0001177_atelectasis | 0.99811843 |
108 | MP0010234_abnormal_vibrissa_follicle | 0.98479790 |
109 | MP0008875_abnormal_xenobiotic_pharmacok | 0.98412375 |
110 | MP0005085_abnormal_gallbladder_physiolo | 0.98318988 |
111 | MP0005360_urolithiasis | 0.97369428 |
112 | MP0003632_abnormal_nervous_system | 0.97165239 |
113 | MP0005595_abnormal_vascular_smooth | 0.96449223 |
114 | MP0001533_abnormal_skeleton_physiology | 0.96382345 |
115 | MP0005508_abnormal_skeleton_morphology | 0.96331981 |
116 | MP0000534_abnormal_ureter_morphology | 0.95904878 |
117 | MP0005076_abnormal_cell_differentiation | 0.95388859 |
118 | MP0003075_altered_response_to | 0.95244960 |
119 | MP0002090_abnormal_vision | 0.94920360 |
120 | MP0003283_abnormal_digestive_organ | 0.94819808 |
121 | MP0003950_abnormal_plasma_membrane | 0.94763043 |
122 | MP0005551_abnormal_eye_electrophysiolog | 0.93982638 |
123 | MP0000733_abnormal_muscle_development | 0.93981118 |
124 | MP0008874_decreased_physiological_sensi | 0.93143863 |
125 | MP0000343_altered_response_to | 0.90612261 |
126 | MP0004947_skin_inflammation | 0.89701575 |
127 | MP0001299_abnormal_eye_distance/ | 0.87947606 |
128 | MP0005621_abnormal_cell_physiology | 0.87116756 |
129 | MP0005166_decreased_susceptibility_to | 0.86956098 |
130 | MP0001851_eye_inflammation | 0.85359611 |
131 | MP0009384_cardiac_valve_regurgitation | 0.85346688 |
132 | MP0001243_abnormal_dermal_layer | 0.85221420 |
133 | MP0002069_abnormal_eating/drinking_beha | 0.85034549 |
134 | MP0001765_abnormal_ion_homeostasis | 0.84589637 |
135 | MP0003172_abnormal_lysosome_physiology | 0.83614379 |
136 | MP0003183_abnormal_peptide_metabolism | 0.80516502 |
137 | MP0005167_abnormal_blood-brain_barrier | 0.78456940 |
138 | MP0005390_skeleton_phenotype | 0.78177321 |
139 | MP0003436_decreased_susceptibility_to | 0.77294112 |
140 | MP0002152_abnormal_brain_morphology | 0.77293402 |
141 | MP0004883_abnormal_blood_vessel | 0.77279600 |
142 | MP0000747_muscle_weakness | 0.77111006 |
143 | MP0003868_abnormal_feces_composition | 0.77017290 |
144 | MP0005083_abnormal_biliary_tract | 0.76498749 |
145 | MP0004085_abnormal_heartbeat | 0.76043069 |
146 | MP0000465_gastrointestinal_hemorrhage | 0.75119972 |
147 | MP0003724_increased_susceptibility_to | 0.74949606 |
148 | MP0001664_abnormal_digestion | 0.74228563 |
149 | MP0004130_abnormal_muscle_cell | 0.73503466 |
150 | MP0005623_abnormal_meninges_morphology | 0.73011864 |
151 | MP0003045_fibrosis | 0.72090431 |
152 | MP0001963_abnormal_hearing_physiology | 0.72004648 |
153 | MP0001614_abnormal_blood_vessel | 0.71709818 |
154 | MP0000569_abnormal_digit_pigmentation | 0.71281918 |
155 | MP0002118_abnormal_lipid_homeostasis | 0.70574427 |
156 | MP0008872_abnormal_physiological_respon | 0.69973827 |
157 | MP0004036_abnormal_muscle_relaxation | 0.69689483 |
158 | MP0008961_abnormal_basal_metabolism | 0.66810343 |
159 | MP0005451_abnormal_body_composition | 0.66315405 |
160 | MP0005365_abnormal_bile_salt | 0.66292475 |
161 | MP0001485_abnormal_pinna_reflex | 0.66098677 |
162 | MP0003795_abnormal_bone_structure | 0.66021139 |
163 | MP0000751_myopathy | 0.65164473 |
164 | MP0005332_abnormal_amino_acid | 0.64905937 |
165 | MP0010329_abnormal_lipoprotein_level | 0.64752491 |
166 | MP0002078_abnormal_glucose_homeostasis | 0.64478947 |
167 | MP0000003_abnormal_adipose_tissue | 0.63984848 |
168 | MP0002876_abnormal_thyroid_physiology | 0.63610588 |
169 | MP0000230_abnormal_systemic_arterial | 0.63290880 |
170 | MP0004510_myositis | 0.62681681 |
171 | MP0000762_abnormal_tongue_morphology | 0.62656854 |
172 | MP0000428_abnormal_craniofacial_morphol | 0.61751562 |
173 | MP0001175_abnormal_lung_morphology | 0.60234221 |
174 | MP0000249_abnormal_blood_vessel | 0.60153548 |
175 | MP0002128_abnormal_blood_circulation | 0.58778379 |
176 | MP0005197_abnormal_uvea_morphology | 0.57281169 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 5.73475713 |
2 | Premature rupture of membranes (HP:0001788) | 5.14508465 |
3 | Myokymia (HP:0002411) | 4.84818820 |
4 | Protrusio acetabuli (HP:0003179) | 4.71189471 |
5 | Neurofibrillary tangles (HP:0002185) | 4.50575351 |
6 | Focal seizures (HP:0007359) | 4.37509437 |
7 | Visual hallucinations (HP:0002367) | 4.16713997 |
8 | Arterial tortuosity (HP:0005116) | 4.03744938 |
9 | Atonic seizures (HP:0010819) | 4.02337021 |
10 | Cerebral inclusion bodies (HP:0100314) | 4.02121498 |
11 | Vascular tortuosity (HP:0004948) | 3.98234267 |
12 | Supranuclear gaze palsy (HP:0000605) | 3.93391671 |
13 | Action tremor (HP:0002345) | 3.64663054 |
14 | Absence seizures (HP:0002121) | 3.57222007 |
15 | Aortic dissection (HP:0002647) | 3.54320871 |
16 | Atrophic scars (HP:0001075) | 3.45266475 |
17 | Epileptic encephalopathy (HP:0200134) | 3.43133339 |
18 | Termporal pattern (HP:0011008) | 3.37886004 |
19 | Insidious onset (HP:0003587) | 3.37886004 |
20 | Generalized tonic-clonic seizures (HP:0002069) | 3.30239388 |
21 | Dialeptic seizures (HP:0011146) | 3.23942123 |
22 | Abnormality of the corticospinal tract (HP:0002492) | 3.06584507 |
23 | Ankle clonus (HP:0011448) | 3.06302906 |
24 | Dysmetria (HP:0001310) | 3.04239258 |
25 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.99953713 |
26 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.99953713 |
27 | Intention tremor (HP:0002080) | 2.97837933 |
28 | Pheochromocytoma (HP:0002666) | 2.97719084 |
29 | Aortic aneurysm (HP:0004942) | 2.97104437 |
30 | Progressive cerebellar ataxia (HP:0002073) | 2.97019442 |
31 | Cerebral aneurysm (HP:0004944) | 2.93541787 |
32 | Vertebral compression fractures (HP:0002953) | 2.87960366 |
33 | Scanning speech (HP:0002168) | 2.86259902 |
34 | Spastic gait (HP:0002064) | 2.84548340 |
35 | Osteolytic defects of the hand bones (HP:0009699) | 2.77632316 |
36 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.77632316 |
37 | Papilledema (HP:0001085) | 2.77006967 |
38 | Truncal ataxia (HP:0002078) | 2.73747649 |
39 | Wormian bones (HP:0002645) | 2.73135895 |
40 | Febrile seizures (HP:0002373) | 2.72062825 |
41 | Hyperventilation (HP:0002883) | 2.67965699 |
42 | Anxiety (HP:0000739) | 2.67344377 |
43 | Dysdiadochokinesis (HP:0002075) | 2.66768462 |
44 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.62033795 |
45 | Dilatation of the ascending aorta (HP:0005111) | 2.61484143 |
46 | Depression (HP:0000716) | 2.61477522 |
47 | Ankle contracture (HP:0006466) | 2.58049215 |
48 | Bladder diverticulum (HP:0000015) | 2.57457166 |
49 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.55491514 |
50 | Urinary urgency (HP:0000012) | 2.54756233 |
51 | Neuroendocrine neoplasm (HP:0100634) | 2.54434786 |
52 | Mitral stenosis (HP:0001718) | 2.53054094 |
53 | Fragile skin (HP:0001030) | 2.52712026 |
54 | Postural instability (HP:0002172) | 2.48231285 |
55 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.48066742 |
56 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.48066742 |
57 | Abnormality of glycolipid metabolism (HP:0010969) | 2.48066742 |
58 | Poor eye contact (HP:0000817) | 2.47067048 |
59 | Agitation (HP:0000713) | 2.46194104 |
60 | Abnormal eating behavior (HP:0100738) | 2.44690677 |
61 | Impaired social interactions (HP:0000735) | 2.40489822 |
62 | Abnormal social behavior (HP:0012433) | 2.40489822 |
63 | Mitral valve prolapse (HP:0001634) | 2.39507504 |
64 | Broad-based gait (HP:0002136) | 2.37985269 |
65 | Overgrowth (HP:0001548) | 2.36853595 |
66 | Increased circulating renin level (HP:0000848) | 2.36817009 |
67 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.34412861 |
68 | Cervical subluxation (HP:0003308) | 2.34388752 |
69 | Peritonitis (HP:0002586) | 2.33801116 |
70 | Drooling (HP:0002307) | 2.31679058 |
71 | Excessive salivation (HP:0003781) | 2.31679058 |
72 | Mutism (HP:0002300) | 2.30716183 |
73 | Progressive inability to walk (HP:0002505) | 2.29952407 |
74 | Megalencephaly (HP:0001355) | 2.28337205 |
75 | Lower limb muscle weakness (HP:0007340) | 2.28256501 |
76 | Cerebral hemorrhage (HP:0001342) | 2.27400845 |
77 | Spinal rigidity (HP:0003306) | 2.26359003 |
78 | Gaze-evoked nystagmus (HP:0000640) | 2.25329582 |
79 | Epileptiform EEG discharges (HP:0011182) | 2.21835123 |
80 | Ankyloglossia (HP:0010296) | 2.20801365 |
81 | Spondylolisthesis (HP:0003302) | 2.20262905 |
82 | Neuronal loss in central nervous system (HP:0002529) | 2.19718250 |
83 | Torticollis (HP:0000473) | 2.19435990 |
84 | Follicular hyperkeratosis (HP:0007502) | 2.19220870 |
85 | EEG with generalized epileptiform discharges (HP:0011198) | 2.18922120 |
86 | Hemiparesis (HP:0001269) | 2.18601810 |
87 | Dysostosis multiplex (HP:0000943) | 2.17625321 |
88 | Blue sclerae (HP:0000592) | 2.16082840 |
89 | Soft skin (HP:0000977) | 2.15865964 |
90 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.15490054 |
91 | Mucopolysacchariduria (HP:0008155) | 2.15490054 |
92 | Blue irides (HP:0000635) | 2.15483426 |
93 | Generalized myoclonic seizures (HP:0002123) | 2.14232231 |
94 | Interstitial pulmonary disease (HP:0006530) | 2.13666868 |
95 | Genu recurvatum (HP:0002816) | 2.13374837 |
96 | Aneurysm (HP:0002617) | 2.13347240 |
97 | Hemiplegia (HP:0002301) | 2.11598216 |
98 | Status epilepticus (HP:0002133) | 2.11457087 |
99 | Abnormality of dentin (HP:0010299) | 2.11010610 |
100 | Abnormality of oral frenula (HP:0000190) | 2.09782756 |
101 | Hyperextensible skin (HP:0000974) | 2.09453967 |
102 | Onion bulb formation (HP:0003383) | 2.09110154 |
103 | Amblyopia (HP:0000646) | 2.08936794 |
104 | Abnormality of binocular vision (HP:0011514) | 2.08633146 |
105 | Diplopia (HP:0000651) | 2.08633146 |
106 | Hypsarrhythmia (HP:0002521) | 2.08129346 |
107 | Clonus (HP:0002169) | 2.07998170 |
108 | Increased variability in muscle fiber diameter (HP:0003557) | 2.07497667 |
109 | Retinal dysplasia (HP:0007973) | 2.07216238 |
110 | Postural tremor (HP:0002174) | 2.04369934 |
111 | Short nail (HP:0001799) | 2.04125224 |
112 | Shallow orbits (HP:0000586) | 2.02415986 |
113 | Mitral regurgitation (HP:0001653) | 2.01302492 |
114 | Peripheral hypomyelination (HP:0007182) | 2.00419915 |
115 | Distal upper limb amyotrophy (HP:0007149) | 1.99925235 |
116 | Upper limb amyotrophy (HP:0009129) | 1.99925235 |
117 | Rapidly progressive (HP:0003678) | 1.99601096 |
118 | Absent frontal sinuses (HP:0002688) | 1.99494076 |
119 | Vertebral arch anomaly (HP:0008438) | 1.98792252 |
120 | Focal dystonia (HP:0004373) | 1.98079325 |
121 | Neonatal short-limb short stature (HP:0008921) | 1.94760619 |
122 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.94639716 |
123 | Bradykinesia (HP:0002067) | 1.94114493 |
124 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.93526387 |
125 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.93526387 |
126 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.93526387 |
127 | Psychosis (HP:0000709) | 1.91796077 |
128 | Hammertoe (HP:0001765) | 1.91671449 |
129 | Spinal cord lesions (HP:0100561) | 1.91066363 |
130 | Syringomyelia (HP:0003396) | 1.91066363 |
131 | Craniofacial dystonia (HP:0012179) | 1.87399359 |
132 | Hypokalemic alkalosis (HP:0001949) | 1.86218114 |
133 | Rigidity (HP:0002063) | 1.86202872 |
134 | Myocardial infarction (HP:0001658) | 1.85166775 |
135 | Limb dystonia (HP:0002451) | 1.83442074 |
136 | Metabolic alkalosis (HP:0200114) | 1.83403349 |
137 | Tetraparesis (HP:0002273) | 1.81186639 |
138 | Resting tremor (HP:0002322) | 1.80743159 |
139 | Akinesia (HP:0002304) | 1.80149465 |
140 | Gait ataxia (HP:0002066) | 1.79905560 |
141 | Joint laxity (HP:0001388) | 1.79803263 |
142 | Insomnia (HP:0100785) | 1.79750941 |
143 | Apathy (HP:0000741) | 1.78011905 |
144 | Thickened helices (HP:0000391) | 1.77609315 |
145 | Hand muscle atrophy (HP:0009130) | 1.77507035 |
146 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.77167843 |
147 | Amyloidosis (HP:0011034) | 1.75985179 |
148 | Impaired vibratory sensation (HP:0002495) | 1.74763810 |
149 | Lower limb amyotrophy (HP:0007210) | 1.74358347 |
150 | Flat acetabular roof (HP:0003180) | 1.74116462 |
151 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.74033107 |
152 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.73948197 |
153 | Stereotypic behavior (HP:0000733) | 1.72261020 |
154 | Long toe (HP:0010511) | 1.71856216 |
155 | Achilles tendon contracture (HP:0001771) | 1.71279856 |
156 | Abnormality of saccadic eye movements (HP:0000570) | 1.71091773 |
157 | Broad metatarsal (HP:0001783) | 1.70527221 |
158 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.70247661 |
159 | Deep venous thrombosis (HP:0002625) | 1.70014797 |
160 | Type II lissencephaly (HP:0007260) | 1.70001072 |
161 | Ketoacidosis (HP:0001993) | 1.69779057 |
162 | Hyperlipoproteinemia (HP:0010980) | 1.69312803 |
163 | Clumsiness (HP:0002312) | 1.68716612 |
164 | Hyperacusis (HP:0010780) | 1.68611075 |
165 | Broad face (HP:0000283) | 1.68141863 |
166 | Bowel diverticulosis (HP:0005222) | 1.68050828 |
167 | Ulnar bowing (HP:0003031) | 1.67827792 |
168 | Mild short stature (HP:0003502) | 1.67702801 |
169 | Diminished motivation (HP:0000745) | 1.67402892 |
170 | Subacute progressive viral hepatitis (HP:0006572) | 1.66055030 |
171 | Absent speech (HP:0001344) | 1.65963045 |
172 | Spastic tetraparesis (HP:0001285) | 1.65243416 |
173 | Abnormality of the acetabulum (HP:0003170) | 1.64803831 |
174 | Obstructive sleep apnea (HP:0002870) | 1.64588506 |
175 | Buphthalmos (HP:0000557) | 1.64555025 |
176 | Abnormality of salivation (HP:0100755) | 1.64481340 |
177 | Distal lower limb amyotrophy (HP:0008944) | 1.64034671 |
178 | Hyperparathyroidism (HP:0000843) | 1.62155638 |
179 | Asymmetry of the thorax (HP:0001555) | 1.61586902 |
180 | Osteopenia (HP:0000938) | 1.61490955 |
181 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.61353579 |
182 | Type 1 muscle fiber predominance (HP:0003803) | 1.60131396 |
183 | Disproportionate tall stature (HP:0001519) | 1.59990754 |
184 | Loss of speech (HP:0002371) | 1.59956536 |
185 | Striae distensae (HP:0001065) | 1.59628896 |
186 | Cardiovascular calcification (HP:0011915) | 1.58135508 |
187 | Relative macrocephaly (HP:0004482) | 1.57917033 |
188 | Camptodactyly of toe (HP:0001836) | 1.56951918 |
189 | Increased connective tissue (HP:0009025) | 1.55891890 |
190 | Thin bony cortex (HP:0002753) | 1.55776594 |
191 | Slender build (HP:0001533) | 1.55672816 |
192 | Arnold-Chiari malformation (HP:0002308) | 1.55467462 |
193 | Abnormality of the Achilles tendon (HP:0005109) | 1.55017130 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NTRK3 | 3.81918996 |
2 | EPHA4 | 3.27959588 |
3 | PDGFRA | 3.15532255 |
4 | MAP3K9 | 3.13891789 |
5 | NTRK1 | 2.77676750 |
6 | LATS2 | 2.72049107 |
7 | KSR2 | 2.43609840 |
8 | MAP3K4 | 2.33489625 |
9 | STK39 | 2.32885057 |
10 | MARK1 | 2.20806298 |
11 | MINK1 | 2.19913404 |
12 | PAK6 | 2.15287222 |
13 | OXSR1 | 2.03524665 |
14 | NEK9 | 2.00900052 |
15 | DAPK2 | 1.98552081 |
16 | MAP3K2 | 1.89499706 |
17 | TTN | 1.87801847 |
18 | TGFBR2 | 1.84013570 |
19 | TRIB3 | 1.80203618 |
20 | RIPK4 | 1.79335167 |
21 | ERN1 | 1.78962193 |
22 | MAP2K4 | 1.75516697 |
23 | WNK4 | 1.65432621 |
24 | MAP2K7 | 1.64797696 |
25 | TIE1 | 1.62727308 |
26 | PRKD3 | 1.57433570 |
27 | PNCK | 1.56854849 |
28 | NTRK2 | 1.53435142 |
29 | DDR2 | 1.52808022 |
30 | JAK1 | 1.47756084 |
31 | CAMKK1 | 1.47026552 |
32 | ARAF | 1.45603480 |
33 | PAK4 | 1.43889224 |
34 | CDK5 | 1.43464874 |
35 | TESK1 | 1.42852242 |
36 | MAP3K13 | 1.42380272 |
37 | CAMKK2 | 1.41139542 |
38 | FGFR4 | 1.38963206 |
39 | MAP3K6 | 1.37996779 |
40 | MOS | 1.35435355 |
41 | MYLK | 1.35153042 |
42 | FGFR2 | 1.33400921 |
43 | PDGFRB | 1.31488030 |
44 | CASK | 1.31407223 |
45 | LATS1 | 1.29936298 |
46 | WNK1 | 1.29341588 |
47 | KSR1 | 1.29065322 |
48 | PAK3 | 1.28687583 |
49 | UHMK1 | 1.26391890 |
50 | MST1R | 1.26167199 |
51 | MAP3K12 | 1.22451018 |
52 | GRK5 | 1.21140491 |
53 | RET | 1.20511681 |
54 | MAP3K14 | 1.15951737 |
55 | PAK2 | 1.11917706 |
56 | FES | 1.11585589 |
57 | ICK | 1.11570644 |
58 | TNIK | 1.10321554 |
59 | INSRR | 1.07931074 |
60 | CDK19 | 1.07872023 |
61 | CAMK2B | 1.06975040 |
62 | PRKCH | 1.05537440 |
63 | CAMK2A | 1.04757385 |
64 | EPHA2 | 1.03829251 |
65 | SIK1 | 1.03761585 |
66 | TRPM7 | 1.02229153 |
67 | PLK2 | 1.01736784 |
68 | CSNK1G2 | 1.00231589 |
69 | SGK223 | 1.00125586 |
70 | SGK494 | 1.00125586 |
71 | EPHB2 | 0.99195590 |
72 | TYRO3 | 0.98648907 |
73 | MAP3K1 | 0.98572844 |
74 | PHKG2 | 0.96156500 |
75 | PHKG1 | 0.96156500 |
76 | CDK6 | 0.95076407 |
77 | RPS6KA2 | 0.92257420 |
78 | PDPK1 | 0.91289190 |
79 | PRKCG | 0.91064703 |
80 | CAMK1G | 0.90244343 |
81 | WNK3 | 0.89610557 |
82 | FGFR3 | 0.88903317 |
83 | EEF2K | 0.86360157 |
84 | EPHB1 | 0.85843742 |
85 | FER | 0.84553946 |
86 | TYK2 | 0.84383173 |
87 | PTK2B | 0.82058894 |
88 | IRAK3 | 0.81851219 |
89 | ERBB4 | 0.79906279 |
90 | CDC42BPA | 0.78438542 |
91 | CAMK2D | 0.78156640 |
92 | STK11 | 0.77725630 |
93 | PKN2 | 0.77119266 |
94 | ZAP70 | 0.76993475 |
95 | CDK14 | 0.76747696 |
96 | MAP3K3 | 0.76058334 |
97 | PDK1 | 0.74980416 |
98 | PKN1 | 0.74734748 |
99 | PRKCE | 0.74642846 |
100 | CAMK2G | 0.74394832 |
101 | SCYL2 | 0.73197660 |
102 | MAPK13 | 0.73194485 |
103 | STK38 | 0.72260934 |
104 | MAPKAPK5 | 0.72194127 |
105 | LMTK2 | 0.70728119 |
106 | MAP2K3 | 0.70668416 |
107 | YES1 | 0.70433337 |
108 | BCR | 0.69624656 |
109 | FGR | 0.69579890 |
110 | FRK | 0.68363697 |
111 | LIMK1 | 0.66547662 |
112 | CDK15 | 0.65857885 |
113 | CDK18 | 0.65056829 |
114 | RAF1 | 0.64603951 |
115 | SGK1 | 0.61558554 |
116 | DYRK1B | 0.61318831 |
117 | SIK2 | 0.60271966 |
118 | MARK2 | 0.59653567 |
119 | BMPR2 | 0.59280527 |
120 | FYN | 0.58422861 |
121 | BRAF | 0.57729859 |
122 | ROCK2 | 0.57706315 |
123 | MAP2K1 | 0.57289124 |
124 | SGK2 | 0.56669386 |
125 | DAPK1 | 0.56371712 |
126 | PRKG2 | 0.56361876 |
127 | CSK | 0.55863370 |
128 | NEK6 | 0.55318416 |
129 | CAMK1 | 0.55291694 |
130 | ERBB3 | 0.55250738 |
131 | PTK6 | 0.53604616 |
132 | CDK11A | 0.52628309 |
133 | JAK2 | 0.52600597 |
134 | AKT3 | 0.52394260 |
135 | MET | 0.52310635 |
136 | PRKD2 | 0.50913215 |
137 | MAPK7 | 0.50882564 |
138 | CSNK1G3 | 0.50386225 |
139 | PRPF4B | 0.48102415 |
140 | CDK12 | 0.47729526 |
141 | PRKCQ | 0.47613044 |
142 | PINK1 | 0.47495296 |
143 | PTK2 | 0.47482719 |
144 | PRKCZ | 0.47411039 |
145 | MTOR | 0.47410559 |
146 | SRC | 0.46633824 |
147 | HIPK2 | 0.44366030 |
148 | DYRK1A | 0.44229700 |
149 | DMPK | 0.44103651 |
150 | MAPK15 | 0.44022411 |
151 | PRKD1 | 0.43923579 |
152 | SGK3 | 0.42217631 |
153 | CSNK1A1L | 0.42032982 |
154 | RIPK1 | 0.39701108 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 2.56629140 |
2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.43743384 |
3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.26905236 |
4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.25917304 |
5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.09104704 |
6 | Long-term potentiation_Homo sapiens_hsa04720 | 2.01658117 |
7 | Circadian entrainment_Homo sapiens_hsa04713 | 1.99295350 |
8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.97644183 |
9 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.93742395 |
10 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.91835010 |
11 | Morphine addiction_Homo sapiens_hsa05032 | 1.88724777 |
12 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.86464807 |
13 | Olfactory transduction_Homo sapiens_hsa04740 | 1.82926286 |
14 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.82172703 |
15 | Insulin secretion_Homo sapiens_hsa04911 | 1.81149777 |
16 | Focal adhesion_Homo sapiens_hsa04510 | 1.77094788 |
17 | Salivary secretion_Homo sapiens_hsa04970 | 1.74979657 |
18 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.74092179 |
19 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.70388847 |
20 | Other glycan degradation_Homo sapiens_hsa00511 | 1.70264041 |
21 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.70143080 |
22 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.67332788 |
23 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.60514130 |
24 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.57494869 |
25 | Renin secretion_Homo sapiens_hsa04924 | 1.53663335 |
26 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.53659566 |
27 | Taste transduction_Homo sapiens_hsa04742 | 1.49372557 |
28 | Amoebiasis_Homo sapiens_hsa05146 | 1.49331069 |
29 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.46298093 |
30 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.45726790 |
31 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.43965381 |
32 | Long-term depression_Homo sapiens_hsa04730 | 1.41494628 |
33 | Cocaine addiction_Homo sapiens_hsa05030 | 1.40835314 |
34 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.40553245 |
35 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.39557341 |
36 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.35237286 |
37 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.35110306 |
38 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.30669346 |
39 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.25484218 |
40 | Adherens junction_Homo sapiens_hsa04520 | 1.25021711 |
41 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.22897366 |
42 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.20209300 |
43 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.17370257 |
44 | Bladder cancer_Homo sapiens_hsa05219 | 1.15661517 |
45 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.15342279 |
46 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.14443934 |
47 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.11432807 |
48 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.09838875 |
49 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.09590256 |
50 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.09530867 |
51 | Endometrial cancer_Homo sapiens_hsa05213 | 1.09428496 |
52 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.05963551 |
53 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.04595844 |
54 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.03850196 |
55 | Bile secretion_Homo sapiens_hsa04976 | 1.03349569 |
56 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.02280029 |
57 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.01861769 |
58 | Salmonella infection_Homo sapiens_hsa05132 | 1.01178745 |
59 | Phagosome_Homo sapiens_hsa04145 | 1.00850771 |
60 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.00676043 |
61 | Gap junction_Homo sapiens_hsa04540 | 0.99262714 |
62 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.99134348 |
63 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.97766474 |
64 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.97228610 |
65 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.96757280 |
66 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.96679702 |
67 | Shigellosis_Homo sapiens_hsa05131 | 0.96531744 |
68 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.96024878 |
69 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.94490916 |
70 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.94390296 |
71 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.93925510 |
72 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.93396921 |
73 | Axon guidance_Homo sapiens_hsa04360 | 0.93338893 |
74 | Thyroid cancer_Homo sapiens_hsa05216 | 0.92506034 |
75 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.92481205 |
76 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.92446410 |
77 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.89315040 |
78 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.87688522 |
79 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.87531030 |
80 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.86939485 |
81 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.86881324 |
82 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.86725224 |
83 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.86327513 |
84 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.84721110 |
85 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.84212749 |
86 | Pertussis_Homo sapiens_hsa05133 | 0.82917736 |
87 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.82915379 |
88 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.82696055 |
89 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.82535811 |
90 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.82354183 |
91 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.81492146 |
92 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.80302234 |
93 | Malaria_Homo sapiens_hsa05144 | 0.79551897 |
94 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.77587771 |
95 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.77150993 |
96 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.75387560 |
97 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.75132503 |
98 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.74389293 |
99 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.74206356 |
100 | Glioma_Homo sapiens_hsa05214 | 0.74147869 |
101 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.73976447 |
102 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.73817410 |
103 | Prion diseases_Homo sapiens_hsa05020 | 0.73071966 |
104 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.72427895 |
105 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.72240588 |
106 | Platelet activation_Homo sapiens_hsa04611 | 0.71449914 |
107 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.71058082 |
108 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.70212887 |
109 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.69790483 |
110 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.69600700 |
111 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.69277863 |
112 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.68999645 |
113 | Melanogenesis_Homo sapiens_hsa04916 | 0.68812350 |
114 | Hepatitis C_Homo sapiens_hsa05160 | 0.67910188 |
115 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.67098710 |
116 | Tuberculosis_Homo sapiens_hsa05152 | 0.66557266 |
117 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.65816597 |
118 | Prostate cancer_Homo sapiens_hsa05215 | 0.64284344 |
119 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.62084104 |
120 | Leishmaniasis_Homo sapiens_hsa05140 | 0.61505838 |
121 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.61227362 |
122 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.60918480 |
123 | Hepatitis B_Homo sapiens_hsa05161 | 0.60625000 |
124 | Pathways in cancer_Homo sapiens_hsa05200 | 0.60007555 |
125 | Melanoma_Homo sapiens_hsa05218 | 0.59598263 |
126 | Colorectal cancer_Homo sapiens_hsa05210 | 0.58031920 |
127 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.57325654 |
128 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.56921262 |
129 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.56571583 |
130 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.55935531 |
131 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.55701780 |
132 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.54295083 |
133 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52259115 |
134 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.51969927 |
135 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.50936319 |
136 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.49023300 |
137 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.46585547 |
138 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.46398413 |
139 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.45921942 |
140 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.45022301 |
141 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.44298910 |
142 | Endocytosis_Homo sapiens_hsa04144 | 0.43407244 |
143 | Lysosome_Homo sapiens_hsa04142 | 0.42254705 |
144 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.40304550 |
145 | Histidine metabolism_Homo sapiens_hsa00340 | 0.39930653 |
146 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.39715081 |
147 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.39417322 |
148 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.38834472 |
149 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.38774647 |
150 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.38667276 |
151 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.38320366 |
152 | Phototransduction_Homo sapiens_hsa04744 | 0.38153552 |
153 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.37993223 |
154 | Alzheimers disease_Homo sapiens_hsa05010 | 0.36700273 |
155 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.36696375 |
156 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.36041378 |
157 | Mineral absorption_Homo sapiens_hsa04978 | 0.33102144 |
158 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.32585756 |
159 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.30389965 |
160 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.29541970 |